Aptus Capital Advisors, LLC Pfizer Inc Transaction History

Aptus Capital Advisors, LLC

$6.27 Billion
Q3 2024

A detailed history of Aptus Capital Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 99,660 shares of PFE stock, worth $2.66 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

99,660

Previous 258,952 61.51%

Holding current value

$2.66 Million

Previous $7.25 Million 60.19%

% of portfolio

0.05%

Previous 0.14%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$27.7 - $31.39 $4.41 Million - $5 Million	-159,292 Reduced 61.51%	99,660 $2.88 Million
Q2 2024 Jul 31, 2024	BUY	$25.26 - $29.6 $933,584 - $1.09 Million	36,959 Added 16.65%	258,952 $7.25 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $1.04 Million - $1.19 Million	40,097 Added 22.04%	221,993 $6.16 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $1.04 Million - $1.35 Million	-39,784 Reduced 17.95%	181,896 $5.24 Million
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $137,666 - $160,917	4,290 Added 1.97%	221,680 $7.35 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $340,719 - $394,205	9,433 Added 4.54%	217,390 $7.97 Million
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $1.95 Million - $2.54 Million	49,569 Added 31.3%	207,957 $8.48 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $4.15 Million - $5.42 Million	99,487 Added 168.91%	158,388 $8.12 Million
Q3 2022 Nov 02, 2022	BUY	$43.76 - $53.42 $358,175 - $437,242	8,185 Added 16.14%	58,901 $2.58 Million
Q2 2022 Jul 29, 2022	BUY	$46.53 - $55.17 $1.56 Million - $1.85 Million	33,557 Added 195.57%	50,716 $2.66 Million
Q1 2022 May 04, 2022	BUY	$45.75 - $56.69 $464,042 - $575,006	10,143 Added 144.57%	17,159 $888,000
Q4 2021 Feb 02, 2022	BUY	$41.32 - $61.25 $4,379 - $6,492	106 Added 1.53%	7,016 $414,000
Q3 2021 Oct 27, 2021	SELL	$39.25 - $50.42 $25,002 - $32,117	-637 Reduced 8.44%	6,910 $297,000
Q2 2021 Jul 27, 2021	BUY	$35.91 - $40.68 $66,505 - $75,339	1,852 Added 32.52%	7,547 $296,000
Q1 2021 May 06, 2021	SELL	$33.49 - $37.77 $1.49 Million - $1.68 Million	-44,387 Reduced 88.63%	5,695 $206,000
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $205,974 - $261,914	6,154 Added 14.01%	50,082 $1.84 Million
Q3 2020 Oct 19, 2020	SELL	$31.75 - $37.25 $824,960 - $967,866	-25,983 Reduced 37.17%	43,928 $1.61 Million
Q2 2020 Jul 22, 2020	BUY	$30.12 - $36.54 $37,951 - $46,040	1,260 Added 1.84%	69,911 $2.29 Million
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $160,450 - $229,248	-5,936 Reduced 7.96%	68,651 $2.24 Million
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $583,144 - $661,795	-17,714 Reduced 19.19%	74,587 $2.92 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $1.37 Million - $1.77 Million	42,023 Added 83.58%	92,301 $3.32 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $6,064 - $6,809	-164 Reduced 0.33%	50,278 $2.18 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $462,525 - $508,160	12,334 Added 32.37%	50,442 $2.14 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $1.47 Million - $1.67 Million	38,108 New	38,108 $1.66 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.

Account

Aptus Capital Advisors, LLC Pfizer Inc Transaction History